Global Novel Coronavirus (COVID-19) Drugs Market Growth (Status and Outlook) 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Novel Coronavirus (COVID-19) Drugs will have significant change from previous year. By the most conservative estimates of global Novel Coronavirus (COVID-19) Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Novel Coronavirus (COVID-19) Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Novel Coronavirus (COVID-19) Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Novel Coronavirus (COVID-19) Drugs, covering the supply chain analysis, impact assessment to the Novel Coronavirus (COVID-19) Drugs market size growth rate in several scenarios, and the measures to be undertaken by Novel Coronavirus (COVID-19) Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Vaccine
Tablet
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Adults (Non-pregnant)
Pregnant Women
Children
Olders
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
National Institute of Allergy and Infectious Diseases
Entos Pharmaceuticals
King Abdullah International Medical Research Center
Philipps University Marburg Medical Center
Naval Medical Research Center
CanSino Biologics
Gilead
SAB Biotherapeutics
Inovio
Novavax
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Novel Coronavirus (COVID-19) Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Novel Coronavirus (COVID-19) Drugs market by identifying its various subsegments.
Focuses on the key global Novel Coronavirus (COVID-19) Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Novel Coronavirus (COVID-19) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Novel Coronavirus (COVID-19) Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Novel Coronavirus (COVID-19) Drugs?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Novel Coronavirus (COVID-19) Drugs Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Novel Coronavirus (COVID-19) Drugs Market Size 2015-2025
2.1.2 Novel Coronavirus (COVID-19) Drugs Market Size CAGR by Region
2.2 Novel Coronavirus (COVID-19) Drugs Segment by Type
2.2.1 Vaccine
2.2.2 Vaccine
2.3 Novel Coronavirus (COVID-19) Drugs Market Size by Type
2.3.1 Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Novel Coronavirus (COVID-19) Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Novel Coronavirus (COVID-19) Drugs Segment by Application
2.4.1 Adults (Non-pregnant)
2.4.2 Pregnant Women
2.4.3 Children
2.4.4 Olders
2.5 Novel Coronavirus (COVID-19) Drugs Market Size by Application
2.5.1 Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Novel Coronavirus (COVID-19) Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Novel Coronavirus (COVID-19) Drugs by Players
3.1 Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Players
3.1.1 Global Novel Coronavirus (COVID-19) Drugs Market Size by Players (2018-2020)
3.1.2 Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Novel Coronavirus (COVID-19) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Novel Coronavirus (COVID-19) Drugs by Regions
4.1 Novel Coronavirus (COVID-19) Drugs Market Size by Regions
4.2 Americas Novel Coronavirus (COVID-19) Drugs Market Size Growth
4.3 APAC Novel Coronavirus (COVID-19) Drugs Market Size Growth
4.4 Europe Novel Coronavirus (COVID-19) Drugs Market Size Growth
4.5 Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Growth
5 Americas
5.1 Americas Novel Coronavirus (COVID-19) Drugs Market Size by Countries
5.2 Americas Novel Coronavirus (COVID-19) Drugs Market Size by Type
5.3 Americas Novel Coronavirus (COVID-19) Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Novel Coronavirus (COVID-19) Drugs Market Size by Regions
6.2 APAC Novel Coronavirus (COVID-19) Drugs Market Size by Type
6.3 APAC Novel Coronavirus (COVID-19) Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Novel Coronavirus (COVID-19) Drugs by Countries
7.2 Europe Novel Coronavirus (COVID-19) Drugs Market Size by Type
7.3 Europe Novel Coronavirus (COVID-19) Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Novel Coronavirus (COVID-19) Drugs by Countries
8.2 Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size by Type
8.3 Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Novel Coronavirus (COVID-19) Drugs Market Forecast
10.1 Global Novel Coronavirus (COVID-19) Drugs Market Size Forecast (2021-2025)
10.2 Global Novel Coronavirus (COVID-19) Drugs Forecast by Regions
10.2.1 Global Novel Coronavirus (COVID-19) Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Novel Coronavirus (COVID-19) Drugs Forecast by Type
10.8 Global Novel Coronavirus (COVID-19) Drugs Forecast by Application
11 Key Players Analysis
11.1 National Institute of Allergy and Infectious Diseases
11.1.1 Company Details
11.1.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.1.3 National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 National Institute of Allergy and Infectious Diseases News
11.2 Entos Pharmaceuticals
11.2.1 Company Details
11.2.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.2.3 Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Entos Pharmaceuticals News
11.3 King Abdullah International Medical Research Center
11.3.1 Company Details
11.3.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.3.3 King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 King Abdullah International Medical Research Center News
11.4 Philipps University Marburg Medical Center
11.4.1 Company Details
11.4.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.4.3 Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Philipps University Marburg Medical Center News
11.5 Naval Medical Research Center
11.5.1 Company Details
11.5.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.5.3 Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Naval Medical Research Center News
11.6 CanSino Biologics
11.6.1 Company Details
11.6.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.6.3 CanSino Biologics Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 CanSino Biologics News
11.7 Gilead
11.7.1 Company Details
11.7.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.7.3 Gilead Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Gilead News
11.8 SAB Biotherapeutics
11.8.1 Company Details
11.8.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.8.3 SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 SAB Biotherapeutics News
11.9 Inovio
11.9.1 Company Details
11.9.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.9.3 Inovio Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Inovio News
11.10 Novavax
11.10.1 Company Details
11.10.2 Novel Coronavirus (COVID-19) Drugs Product Offered
11.10.3 Novavax Novel Coronavirus (COVID-19) Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Novavax News
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Novel Coronavirus (COVID-19) Drugs Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Novel Coronavirus (COVID-19) Drugs Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Novel Coronavirus (COVID-19) Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Vaccine
Table 7. Major Players of Tablet
Table 8. Novel Coronavirus (COVID-19) Drugs Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
Table 10. Global Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application (2015-2020)
Table 12. Global Novel Coronavirus (COVID-19) Drugs Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Novel Coronavirus (COVID-19) Drugs Revenue Market Share by Players (2018-2020)
Table 14. Global Novel Coronavirus (COVID-19) Drugs Key Players Head office and Products Offered
Table 15. Novel Coronavirus (COVID-19) Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Novel Coronavirus (COVID-19) Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Regions 2015-2020
Table 20. Americas Novel Coronavirus (COVID-19) Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Countries (2015-2020)
Table 22. Americas Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
Table 24. Americas Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application (2015-2020)
Table 26. APAC Novel Coronavirus (COVID-19) Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Regions (2015-2020)
Table 28. APAC Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
Table 30. APAC Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application (2015-2020)
Table 32. Europe Novel Coronavirus (COVID-19) Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Countries (2015-2020)
Table 34. Europe Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
Table 36. Europe Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Novel Coronavirus (COVID-19) Drugs
Table 45. Key Application and Potential Industries of Novel Coronavirus (COVID-19) Drugs
Table 46. Key Challenges of Novel Coronavirus (COVID-19) Drugs
Table 47. Key Trends of Novel Coronavirus (COVID-19) Drugs
Table 48. Global Novel Coronavirus (COVID-19) Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share Forecast by Regions
Table 50. Global Novel Coronavirus (COVID-19) Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Novel Coronavirus (COVID-19) Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 54. National Institute of Allergy and Infectious Diseases Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 55. National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Product Offered
Table 56. National Institute of Allergy and Infectious Diseases Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 57. National Institute of Allergy and Infectious Diseases Main Business
Table 58. National Institute of Allergy and Infectious Diseases Latest Developments
Table 59. Entos Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 60. Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Product Offered
Table 61. Entos Pharmaceuticals Main Business
Table 62. Entos Pharmaceuticals Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 63. Entos Pharmaceuticals Latest Developments
Table 64. King Abdullah International Medical Research Center Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 65. King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Product Offered
Table 66. King Abdullah International Medical Research Center Main Business
Table 67. King Abdullah International Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 68. King Abdullah International Medical Research Center Latest Developments
Table 69. Philipps University Marburg Medical Center Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 70. Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Product Offered
Table 71. Philipps University Marburg Medical Center Main Business
Table 72. Philipps University Marburg Medical Center Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 73. Philipps University Marburg Medical Center Latest Developments
Table 74. Naval Medical Research Center Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 75. Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Product Offered
Table 76. Naval Medical Research Center Main Business
Table 77. Naval Medical Research Center Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 78. Naval Medical Research Center Latest Developments
Table 79. CanSino Biologics Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 80. CanSino Biologics Novel Coronavirus (COVID-19) Drugs Product Offered
Table 81. CanSino Biologics Main Business
Table 82. CanSino Biologics Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 83. CanSino Biologics Latest Developments
Table 84. Gilead Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 85. Gilead Novel Coronavirus (COVID-19) Drugs Product Offered
Table 86. Gilead Main Business
Table 87. Gilead Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 88. Gilead Latest Developments
Table 89. SAB Biotherapeutics Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 90. SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Product Offered
Table 91. SAB Biotherapeutics Main Business
Table 92. SAB Biotherapeutics Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 93. SAB Biotherapeutics Latest Developments
Table 94. Inovio Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 95. Inovio Novel Coronavirus (COVID-19) Drugs Product Offered
Table 96. Inovio Main Business
Table 97. Inovio Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 98. Inovio Latest Developments
Table 99. Novavax Details, Company Total Revenue (in $ million), Head Office, Novel Coronavirus (COVID-19) Drugs Major Market Areas and Its Competitors
Table 100. Novavax Novel Coronavirus (COVID-19) Drugs Product Offered
Table 101. Novavax Main Business
Table 102. Novavax Novel Coronavirus (COVID-19) Drugs Revenue and Gross Margin (2018-2020E)
Table 103. Novavax Latest Developments
List of Figures
Figure 1. Novel Coronavirus (COVID-19) Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Novel Coronavirus (COVID-19) Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Vaccine Market Size Growth Rate
Figure 6. Global Tablet Market Size Growth Rate
Figure 7. Novel Coronavirus (COVID-19) Drugs in Adults (Non-pregnant)
Figure 8. Global Novel Coronavirus (COVID-19) Drugs Market: Adults (Non-pregnant) (2015-2020) ($ Millions)
Figure 9. Novel Coronavirus (COVID-19) Drugs in Pregnant Women
Figure 10. Global Novel Coronavirus (COVID-19) Drugs Market: Pregnant Women (2015-2020) ($ Millions)
Figure 11. Novel Coronavirus (COVID-19) Drugs in Children
Figure 12. Global Novel Coronavirus (COVID-19) Drugs Market: Children (2015-2020) ($ Millions)
Figure 13. Global Children YoY Growth ($ Millions)
Figure 14. Novel Coronavirus (COVID-19) Drugs in Olders
Figure 15. Global Novel Coronavirus (COVID-19) Drugs Market: Olders (2015-2020) ($ Millions)
Figure 16. Global Olders YoY Growth ($ Millions)
Figure 17. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application in 2019
Figure 18. Global Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Regions 2015-2020
Figure 19. Americas Novel Coronavirus (COVID-19) Drugs Market Size 2015-2020 ($ Millions)
Figure 20. APAC Novel Coronavirus (COVID-19) Drugs Market Size 2015-2020 ($ Millions)
Figure 21. Europe Novel Coronavirus (COVID-19) Drugs Market Size 2015-2020 ($ Millions)
Figure 22. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size 2015-2020 ($ Millions)
Figure 23. Americas Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Countries in 2019
Figure 24. Americas Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type in 2019
Figure 25. Americas Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application in 2019
Figure 26. United States Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 27. Canada Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 28. Mexico Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 29. APAC Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Regions in 2019
Figure 30. APAC Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type in 2019
Figure 31. APAC Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application in 2019
Figure 32. China Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 33. Japan Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 34. Korea Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 35. Southeast Asia Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 36. India Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. Australia Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 38. Europe Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Countries in 2019
Figure 39. Europe Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type in 2019
Figure 40. Europe Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application in 2019
Figure 41. Germany Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 42. France Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 43. UK Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 44. Italy Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 45. Russia Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. Spain Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 47. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Countries in 2019
Figure 48. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Type in 2019
Figure 49. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size Market Share by Application in 2019
Figure 50. Egypt Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 51. South Africa Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 52. Israel Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 53. Turkey Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 54. GCC Countries Novel Coronavirus (COVID-19) Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 55. Global Novel Coronavirus (COVID-19) Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 56. Americas Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 57. APAC Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 58. Europe Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 59. Middle East & Africa Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 60. United States Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 61. Canada Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 62. Mexico Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 63. Brazil Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 64. China Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 65. Japan Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 66. Korea Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 67. Southeast Asia Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 68. India Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 69. Australia Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 70. Germany Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 71. France Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 72. UK Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 73. Italy Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 74. Russia Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 75. Spain Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 76. Egypt Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 77. South Africa Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 78. Israel Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 79. Turkey Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Figure 80. GCC Countries Novel Coronavirus (COVID-19) Drugs Market Size 2021-2025 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets